Clinical Trials Logo

Filter by:
NCT ID: NCT05476978 Completed - Clinical trials for Pancreatic Ductal Adenocarcinoma

Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions

Start date: July 1, 2022
Phase:
Study type: Observational

We aim to develop an EUS-AI model which can facilitate clinical diagnosis by analyzing EUS pictures and clinical parameters of patients.

NCT ID: NCT05476341 Completed - Lung Cancer Clinical Trials

A Phase I Clinical Trial of Bevacizumab Injection

Start date: April 6, 2017
Phase: Phase 1
Study type: Interventional

Recombinant humanized monoclonal antibody injection against human vascular endothelial growth factor (bevacizumab) is Avastin produced by Zhengda Tianqing Pharmaceutical Group Co., Ltd Biological similar drugs. Its mechanism is to prevent VEGF from binding to its natural receptor VEGFR, inhibit the proliferation and activation of vascular endothelial cells, and play an anti angiogenesis and anti-tumor role by binding with VEGF. A randomized, double-blind, single dose, parallel comparison of bevacizumab injection and Avastin is planned The phase I clinical study on the similarity of pharmacokinetics and safety of traditional Chinese medicine in healthy male volunteers aims to compare bevacizumab injection with Avastin The similarity of pharmacokinetics, tolerance, safety and immunogenicity.

NCT ID: NCT05476068 Completed - Dry Eye Symptoms Clinical Trials

Dry Eye Under China's Dynamic COVID-zero Strategy

Start date: March 20, 2022
Phase:
Study type: Observational

To compare the prevalence of dry eye symptoms and to investigate the association of the risk factors with the dry eye symptomatology among university students in the epidemic and non-epidemic areas of China under the COVID-zero strategy.

NCT ID: NCT05475990 Completed - Adverse Effect Clinical Trials

Comparison of Hydroxyethyl Starch and Crystalloid Coload Combined With Norepinephrine Infusion for Hypotension

Start date: January 11, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) or crystalloid coload combined with prophylactic norepinephrine infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.

NCT ID: NCT05475938 Completed - Bone Tumors Clinical Trials

Application of Painting Analysis and Psychotherapy in Children With Bone Tumors

Start date: October 20, 2021
Phase: N/A
Study type: Interventional

In the population suffering from cancer, children and teenagers are in the majority. For children with rapid development of body and mind, with the change of cognitive ability, they will feel anxiety and fear about the expected potential negative events. Painting art therapy is a kind of non-verbal psychological therapy through the interaction between the painter, the painting work and the therapist, with the painting creation activity as the intermediary. The purpose is to develop symbolic language, touch the inner subconscious, and integrate into the personality, so as to produce cognitive and behavioral changes. Painting therapy and psychological analysis can improve the treatment compliance of children bone tumor patients, make psychological nursing and health education of patients more targeted, and promote the cooperation between medical care and patients.

NCT ID: NCT05475873 Completed - Adverse Effect Clinical Trials

Ondansetron for Postspinal Anesthesia Hypotension

Start date: June 18, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effectiveness of ondansetron for postspinal anesthesia hypotension in patients undergoing cesarean section.

NCT ID: NCT05475834 Completed - Clinical trials for Healthy Male Volunteers

Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants

Start date: July 21, 2022
Phase: Phase 1
Study type: Interventional

This is a non-randomized, open-label, single-dose, Phase I clinical study to evaluate the mass balance and biotransformation, safety and tolerability of SIM0417 in healthy Chinese adult male subjects following a single oral administration of SIM0417 in combination with ritonavir.

NCT ID: NCT05475418 Completed - Wounds and Injuries Clinical Trials

Pilot Study of Human Adipose Tissue Derived Exosomes Promoting Wound Healing

Start date: August 5, 2022
Phase: N/A
Study type: Interventional

This study is a one-arm pilot study. All patients were recruited on an outpatient basis. After screening visits and informed consent was obtained, debridement and photography were performed on the patient's wound surface, and the wound area was measured. Patients in the intervention group were then provided with adipose tissue exosome dressings.200-300ml of the subject adipose tissue before centrifugation was collected, and the extracellular vesicles were retained after tissue homogenate and filter screening. The extracellular vesicles were mixed with sterile hydrogel and applied directly to the wound surface, and the wound was covered with an inert protective dressing.

NCT ID: NCT05474755 Completed - Influenza Clinical Trials

To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus Infection

Start date: July 28, 2022
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy, safety, and population pharmacokinetics of a single, oral dose of GP681 compared with placebo in patients aged 12 to 65 years with acute uncomplicated influenza virus infection

NCT ID: NCT05473728 Completed - Pain, Postoperative Clinical Trials

Epidemiology Study and Risk Factor Analysis on Chronic Post-surgical Pain After Video-assisted Thoracic Surgery

Start date: August 1, 2022
Phase:
Study type: Observational

This study is a nationwide multi-center study to investigate the incidence and risk factors of chronic post-surgical pain (CPSP) after receiving video-assisted thoracic surgery (VATS). Patients receiving VATS in participating centers across China in Aug. 2022 will be assessed for eligibility, and all the enrolled patients will be followed up for at least 6 months. The study's primary outcome is the incidence of CPSP 6 months after VATS. Baseline demographic, psychological , surgical, anesthesia-related and pain-related characteristics will be evaluated for possible risk factors of CPSP after VATS.